Výsledky vyhledávání - Jean‐Jacques Body
- Zobrazuji výsledky 1 - 20 z 48
- Přejít na další stránku
-
1
-
2
Breast Cancer: Bisphosphonate Therapy for Metastatic Bone Disease Autor Jean‐Jacques Body
Vydáno 2006Revisão -
3
Epinephrine is a Hypophosphatemic Hormone in Man. PHYSIOLOGICAL EFFECTS OF CIRCULATING EPINEPHRINE ON PLASMA CALCIUM, MAGNESIUM, PHOSPHORUS, PARATHYROID HORMONE, AND CALCITONIN Autor Jean‐Jacques Body, Philip E. Cryer, Kenneth P. Offord, Hunter Heath
Vydáno 1983Artigo -
4
-
5
-
6
-
7
-
8
The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts Autor Hichame Id Boufker, Laurence Lagneaux, Mehdi Najar, Martine Piccart, Ghanem Ghanem, Jean‐Jacques Body, Fabrice Journé
Vydáno 2010Artigo -
9
-
10
Bariatric surgery and skeletal health: A narrative review and position statement for management by the European Calcified Tissue Society (ECTS) Autor Julien Paccou, Elena Tsourdi, Christian Meier, Andrea Palermo, Jessica Pepe, Jean-Jacques Body, M. Carola Zillikens
Vydáno 2021Revisão -
11
Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studie... Autor Jean‐Jacques Body, Ingo Diel, M. Lichinitzer, A. F Lazarev, Martin Pecherstorfer, R. Bell, Debu Tripathy, B. Bergström
Vydáno 2004Artigo -
12
Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS Autor Athanasios D. Anastasilakis, Jessica Pepe, Nicola Napoli, Andrea Palermo, Christos Magopoulos, Aliya Khan, M. Carola Zillikens, Jean-Jacques Body
Vydáno 2021Revisão -
13
-
14
-
15
A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer. Autor Jean-Jacques Body, Thierry Façon, Robert E. Coleman, Allan Lipton, F. Geurs, Michelle Fan, Donna Holloway, Mark Peterson, Pirow Bekker
Vydáno 2006Artigo -
16
-
17
Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates Autor Karim Fizazi, Allan Lipton, Xavier Mariette, Jean‐Jacques Body, Yasmin Rahim, Julie R. Gralow, Guozhi Gao, Ling Wu, Winnie Sohn, Susie Jun
Vydáno 2009Artigo -
18
Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club Autor Michaël R. Laurent, Stefan Goemaere, Charlotte Verroken, Pierre Bergmann, Jean‐Jacques Body, Olivier Bruyère, Étienne Cavalier, Serge Rozenberg, Bruno Lapauw, Evelien Gielen
Vydáno 2022Revisão -
19
-
20
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Osteoporosis
Cancer
Oncology
Pathology
Breast cancer
Denosumab
Bone mineral
Intensive care medicine
Surgery
Urology
Zoledronic acid
Alternative medicine
Bisphosphonate
Endocrinology
Bone metastasis
Bone remodeling
Placebo
Biology
Calcium
Clinical trial
Family medicine
Osteonecrosis of the jaw
Vitamin D and neurology
Adverse effect
Bone disease
Bone resorption
Chemistry
Disease